Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Abbott Laboratories and its Massachusetts biotech partner have launched a final-stage clinical trial of their experimental treatment for multiple sclerosis.
The first patient — out of 1,500 needed worldwide — was enrolled last month in the U.S. The drug, daclizumab, is being developed for monthly injection under the patient’s skin by North Chicago-based Abbott and Cambridge-based Biogen Idec. Get the full story »
The Postal Regulatory Commission heard testimony Monday from businesses that oppose an end to mail delivery on Saturdays, a move the postal service says would save more than $3 billion annually.
Among them, CVS Caremark Co. said a five-day delivery service would impede the growth of mail-order pharmaceuticals and keep vital medications from patients. Get the full story »
